EFFECTS OF DIETARY FATS ON LIPOPROTEIN METABOLISM
膳食脂肪对脂蛋白代谢的影响
基本信息
- 批准号:3356144
- 负责人:
- 金额:$ 22.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-07-01 至 1990-06-30
- 项目状态:已结题
- 来源:
- 关键词:apolipoproteins atherosclerosis blood chemistry blood coagulation tests blood lipoprotein blood lipoprotein metabolism blood pressure caloric dietary content cholesterol coronary disorder delayed hypersensitivity diet route /schedule diet therapy dietary lipid disease /disorder prevention /control eicosanoids enzyme linked immunosorbent assay essential fatty acids gas chromatography gas chromatography mass spectrometry gel electrophoresis high density lipoproteins human subject hyperlipidemia immunologic skin test linoleate linolenate lipoprotein disorder longitudinal human study low density lipoprotein lymphokines nutrient requirement nutrition related tag omega 3 fatty acid phospholipids platelet aggregation prostaglandin E prostaglandin F radioimmunoassay saturated fatty acids thin layer chromatography thromboxanes triglycerides ultracentrifugation very low density lipoprotein
项目摘要
An increased dietary intake of saturated fat and cholesterol has
been associated with elevations in plasma cholesterol and low
density lipoprotein (LDL) cholesterol levels, decreased bleeding
time, enhanced platelet aggregation, alterations in immune
function, and an increased risk of developing premature coronary
artery disease (CAD). An increased dietary intake of
polyunsaturated fats and/or dietary saturated fat restriction
appears to decrease some of these adverse associations.
Moreover polyunsaturated fats are mainly essential fatty acids
and their daily nutritional requirements have not been established.
The aims of this research are to carry out well controlled diet
studies on the effects of: 1) altering the dietary content of
linoleic acid (0%, 2%. 6% and 8% of calories) or of its derivative
gamma linolenic acid (0% and 2% of calories), 2) altering the
dietary content of linolenic acid (0%, 0.3%, 2%, and 4%) or its
derivatives eicosapentaenoic acid and docosahexaenoic acid (0%
and 2%) of calories; 3) testing the long term effects (1 year) of a
diet containing 10% saturated fat, 100 mg cholesterol/1000
calories, and 10% polyunsaturated fat and a diet containing 5%
saturated fat, 60 mg cholesterol/1000 calories, and 10%
polyunsaturated fat. Diet studies 1 and 2 will be carried out in 10
normolipidemic subjects each and study 3 will be carried out in 20
normolipidemic subjects, 10 subjects with familial hypoalphalipo
proteinemia, and 10 subjects with familial combined
hyperlipidemia. Parameters to be examined will include plasma
lipoprotein lipid content, apolipoproteins A-I, A-II, B, and E, LDL
and HDL subclasses, VLDL and LDL apoB-100 and HDL apoA-I
kinetics, plasma lipoprotein alterations in response to a defined
fat meal (1 gm/kg of fat), platelet thromboxane B2 (a measure of
platelet aggregation), bleeding time, blood pressure, delayed
hypersensitivity response, peripheral blood mononuclear cell
mitogenic response to T and B cell mitogens and lymphokine
formation.
The objectives of the project are to define optimal dietary intakes
of essential fatty acids and their derivatives, saturated fats,
monounsaturated fats, and cholesterol in normal and dyslipidemic
humans in terms of improving parameters associated with
premature CAD (elevated LDL, decreased HDL, increased blood
pressure, and increased bleeding time).
饱和脂肪和胆固醇摄入量的增加
与血浆胆固醇升高和低
密度脂蛋白(LDL)胆固醇水平,减少出血
时间,血小板聚集增强,免疫功能改变,
功能,以及患过早冠状动脉的风险增加
动脉疾病(CAD)。 增加饮食摄入量
多不饱和脂肪和/或膳食饱和脂肪限制
似乎减少了这些不利的联系。
而且多不饱和脂肪主要是必需脂肪酸
他们的日常营养需求尚未确定。
本研究的目的是进行良好的控制饮食,
研究影响:1)改变膳食中的
亚油酸(0%,2%,6%和8%的卡路里)或其衍生物
γ-亚麻酸(0%和2%的卡路里),2)改变
日粮中亚麻酸含量(0%、0.3%、2%和4%)或其
衍生物二十碳五烯酸和二十二碳六烯酸(0%
和2%)的热量; 3)测试长期影响(1年)的一个
含10%饱和脂肪的饮食,100 mg胆固醇/1000
卡路里,10%的多不饱和脂肪,以及含有5%
饱和脂肪,60毫克胆固醇/1000卡路里,10%
多不饱和脂肪 饮食研究1和2将在10
研究3将在20名正常血脂受试者中进行,
血脂正常受试者,10例家族性低血脂受试者
蛋白血症,10例受试者有家族性合并
高脂血症 待检查的参数包括血浆
脂蛋白脂质含量、载脂蛋白A-I、A-II、B和E、LDL
和HDL亚类,VLDL和LDL apoB-100和HDL apoA-I
动力学,血浆脂蛋白改变,以响应定义的
脂肪餐(1 gm/kg脂肪)、血小板血栓素B2(
血小板聚集),出血时间,血压,延迟
超敏反应,外周血单个核细胞
对T和B细胞有丝分裂原和淋巴因子的促有丝分裂反应
阵
该项目的目标是确定最佳饮食摄入量
必需脂肪酸及其衍生物,饱和脂肪,
单不饱和脂肪和胆固醇在正常和血脂异常
人类在改善相关参数方面
早发CAD(LDL升高,HDL降低,血液中
压力和出血时间增加)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERNST JOHN SCHAEFER其他文献
ERNST JOHN SCHAEFER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERNST JOHN SCHAEFER', 18)}}的其他基金
EFFECTS OF EXTENDED-RELEASE NIACIN ON A COMBINATION OF LOVASTATIN
缓释烟酸对洛伐他汀组合的影响
- 批准号:
7200872 - 财政年份:2005
- 资助金额:
$ 22.51万 - 项目类别:
Effects of Extended-Release Niacin on a Combination
缓释烟酸对组合的影响
- 批准号:
7040665 - 财政年份:2004
- 资助金额:
$ 22.51万 - 项目类别:
Effects of Atorvastatin on the Kinetics of APO B-100
阿托伐他汀对 APO B-100 动力学的影响
- 批准号:
7040659 - 财政年份:2004
- 资助金额:
$ 22.51万 - 项目类别:
MOLECULAR BASIS OF HIGH DENSITY LIPOPROTEIN DEFICIENCY
高密度脂蛋白缺乏症的分子基础
- 批准号:
2854266 - 财政年份:1999
- 资助金额:
$ 22.51万 - 项目类别:
Molecular Basis of High Density Lipoprotein Deficiency
高密度脂蛋白缺乏症的分子基础
- 批准号:
7054062 - 财政年份:1999
- 资助金额:
$ 22.51万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 22.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 22.51万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 22.51万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 22.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 22.51万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 22.51万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 22.51万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 22.51万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
- 批准号:
10974007 - 财政年份:2023
- 资助金额:
$ 22.51万 - 项目类别:














{{item.name}}会员




